Cargando...

Comparative Risk of Serious Infections with Biologic and/or Immunosuppressive Therapy in Patients with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis

BACKGROUND AND AIMS: We performed a systematic review and meta-analysis to evaluate the comparative risk of serious infections with tumor necrosis factor-α (TNFα) antagonists, biologic agents that do not inhibit TNFα, tofacitinib, and immunosuppressive agents in inflammatory bowel diseases (IBD). ME...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Gastroenterol Hepatol
Main Authors: Singh, Siddharth, Facciorusso, Antonio, Dulai, Parambir S., Jairath, Vipul, Sandborn, William J.
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8011651/
https://ncbi.nlm.nih.gov/pubmed/30876964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2019.02.044
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!